1. Structure‐Based Design of Bicyclic Helical Peptides That Target the Oncogene β‐Catenin.
- Author
-
Yeste‐Vázquez, Alejandro, Paulussen, Felix M., Wendt, Mathias, Klintrot, Rasmus, Schulte, Clemens, Wallraven, Kerstin, van Gijzel, Lieke, Simeonov, Boris, van der Gaag, Maurice, Gerber, Alan, Maric, Hans M., Hennig, Sven, and Grossmann, Tom N.
- Subjects
- *
PEPTIDES , *PROTEIN-protein interactions , *MOLECULAR weights , *BINDING sites , *CRYSTAL structure - Abstract
The inhibition of intracellular protein‐protein interactions is challenging, in particular, when involved interfaces lack pronounced cavities. The transcriptional co‐activator protein and oncogene β‐catenin is a prime example of such a challenging target. Despite extensive targeting efforts, available high‐affinity binders comprise only large molecular weight inhibitors. This hampers the further development of therapeutically useful compounds. Herein, we report the design of a considerably smaller peptidomimetic scaffold derived from the α‐helical β‐catenin‐binding motif of Axin. Sequence maturation and bicyclization provided a stitched peptide with an unprecedented crosslink architecture. The binding mode and site were confirmed by a crystal structure. Further derivatization yielded a β‐catenin inhibitor with single‐digit micromolar activity in a cell‐based assay. This study sheds light on how to design helix mimetics with reduced molecular weight thereby improving their biological activity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF